loading
전일 마감가:
$21.03
열려 있는:
$21.12
하루 거래량:
659.18K
Relative Volume:
0.56
시가총액:
$2.57B
수익:
$460.48M
순이익/손실:
$142.80M
주가수익비율:
17.83
EPS:
1.18
순현금흐름:
$221.79M
1주 성능:
-2.40%
1개월 성능:
-6.14%
6개월 성능:
-7.94%
1년 성능:
+24.56%
1일 변동 폭
Value
$21.05
$21.42
1주일 범위
Value
$20.60
$21.78
52주 변동 폭
Value
$15.34
$26.58

Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile

Name
명칭
Catalyst Pharmaceuticals Inc
Name
전화
(305) 529-2522
Name
주소
355 ALHAMBRA CIRCLE, CORAL GABLES
Name
직원
167
Name
트위터
@CatalystForRare
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
CPRX's Discussions on Twitter

CPRX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CPRX
Catalyst Pharmaceuticals Inc
21.05 2.64B 460.48M 142.80M 221.79M 1.18
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.21 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.38 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.87 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
567.18 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
290.33 27.29B 3.81B -644.79M -669.77M -6.24

Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-04 개시 Robert W. Baird Outperform
2024-11-18 개시 Stephens Overweight
2024-03-14 개시 Citigroup Buy
2024-03-07 개시 BofA Securities Buy
2023-12-21 개시 Oppenheimer Outperform
2022-08-24 다운그레이드 ROTH Capital Buy → Neutral
2018-09-21 개시 Cantor Fitzgerald Overweight
2018-09-07 재개 Piper Jaffray Overweight
2016-10-05 업그레이드 Piper Jaffray Neutral → Overweight
2016-04-26 다운그레이드 Piper Jaffray Overweight → Neutral
2014-09-30 재확인 ROTH Capital Buy
2014-09-16 재확인 ROTH Capital Buy
2014-09-15 재확인 H.C. Wainwright Buy
2013-10-21 재확인 Aegis Capital Buy
2013-09-24 개시 Maxim Group Buy
2013-09-06 재확인 Aegis Capital Buy
2013-04-18 개시 Aegis Capital Buy
2012-08-27 업그레이드 Rodman & Renshaw Mkt Perform → Mkt Outperform
2009-10-01 업그레이드 Merriman Sell → Neutral
2009-05-29 다운그레이드 Hapoalim Neutral → Underperform
2009-05-29 다운그레이드 Merriman Curhan Ford Buy → Sell
2008-12-15 개시 Merriman Curhan Ford Buy
2007-11-28 개시 Rodman & Renshaw Mkt Outperform
2007-01-31 개시 Stifel Nicolaus Buy
2007-01-05 개시 First Albany Buy
모두보기

Catalyst Pharmaceuticals Inc 주식(CPRX)의 최신 뉴스

pulisher
09:40 AM

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock - Yahoo Finance

09:40 AM
pulisher
Jul 20, 2025

What drives Catalyst Pharmaceuticals Inc. stock priceHigh-octane financial growth - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

What analysts say about Catalyst Pharmaceuticals Inc. stockOverwhelming financial success - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Is Catalyst Pharmaceuticals Inc. a good long term investmentLightning-fast growth - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Catalyst Pharmaceuticals Inc. Stock Analysis and ForecastExceptional profit margins - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Why Catalyst Pharmaceuticals Inc. stock is on top investor watchlistsSafe and Smart Investment Picks - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Published on: 2025-07-17 22:44:23 - Newser

Jul 17, 2025
pulisher
Jul 17, 2025

Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics - Yahoo

Jul 17, 2025
pulisher
Jul 17, 2025

Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics - The Globe and Mail

Jul 17, 2025
pulisher
Jul 16, 2025

Should Value Investors Buy Catalyst Pharmaceuticals (CPRX) Stock? - Yahoo.co

Jul 16, 2025
pulisher
Jul 16, 2025

Teacher Retirement System of Texas Sells 2,766 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

What makes Catalyst Pharmaceuticals Inc. stock price move sharplyFree Stock Tips Group - beatles.ru

Jul 16, 2025
pulisher
Jul 15, 2025

Why Catalyst Pharmaceuticals Inc. stock attracts strong analyst attentionPro Trader Stock Focus - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Catalyst Pharmaceuticals Inc. stock performs during market volatilityRisk Aware High Growth Picks - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Principal Financial Group Inc. Purchases 17,018 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 12, 2025
pulisher
Jul 10, 2025

Amalgamated Bank Decreases Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 10, 2025
pulisher
Jul 10, 2025

Cambridge Investment Research Advisors Inc. Takes Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 10, 2025
pulisher
Jul 09, 2025

GAMMA Investing LLC Acquires 579 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 09, 2025
pulisher
Jul 08, 2025

Institutional investors in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) lost 3.5% last week but have reaped the benefits of longer-term growth - simplywall.st

Jul 08, 2025
pulisher
Jul 08, 2025

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by New York State Teachers Retirement System - Defense World

Jul 08, 2025
pulisher
Jul 07, 2025

Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term - Yahoo Finance

Jul 07, 2025
pulisher
Jul 07, 2025

Allspring Global Investments Holdings LLC Sells 244,148 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 07, 2025
pulisher
Jul 04, 2025

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term - Yahoo Finance

Jul 04, 2025
pulisher
Jul 01, 2025

Catalyst Pharmaceuticals is Now Oversold (CPRX) - Nasdaq

Jul 01, 2025
pulisher
Jun 26, 2025

Top 3 Health Care Stocks You'll Regret Missing This Quarter - inkl

Jun 26, 2025
pulisher
Jun 19, 2025

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock - Nasdaq

Jun 19, 2025
pulisher
Jun 18, 2025

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Reports Strong Q1 2025 Earnings Growth - Yahoo Finance

Jun 18, 2025
pulisher
Jun 16, 2025

Stanley Laman Group Ltd. Acquires New Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat

Jun 16, 2025
pulisher
Jun 15, 2025

GAMMA Investing LLC Has $1.64 Million Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat

Jun 15, 2025
pulisher
Jun 15, 2025

Catalyst Pharmaceuticals (NASDAQ:CPRX) Trading Down 5.2% Following Insider Selling - MarketBeat

Jun 15, 2025
pulisher
Jun 14, 2025

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Insider Sells $42,272.00 in Stock - MarketBeat

Jun 14, 2025
pulisher
Jun 13, 2025

Trading (CPRX) With Integrated Risk Controls - news.stocktradersdaily.com

Jun 13, 2025
pulisher
Jun 13, 2025

Preethi Sundaram Implements A Sell Strategy: Offloads $103K In Catalyst Pharmaceuticals Stock - Nasdaq

Jun 13, 2025
pulisher
Jun 12, 2025

Insider Sell: Preethi Sundaram Sells Shares of Catalyst Pharmaceuticals Inc (CPRX) - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Preethi Sundaram Sells 2,324 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Stock - MarketBeat

Jun 12, 2025
pulisher
Jun 12, 2025

117,374 Shares in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Bought by Bridge City Capital LLC - MarketBeat

Jun 12, 2025
pulisher
Jun 11, 2025

Director Of Catalyst Pharmaceuticals Sold $5.22M In Stock - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Strong Inflows Make Catalyst Stock an Outlier - FXEmpire

Jun 11, 2025
pulisher
Jun 10, 2025

Insider Sell: Patrick Mcenany Sells 200,000 Shares of Catalyst P - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Catalyst Pharmaceuticals, Inc. (CPRX) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Jun 10, 2025
pulisher
Jun 09, 2025

Catalyst Pharmaceuticals stock soars to all-time high of $26.49 By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Catalyst Pharmaceuticals stock soars to all-time high of $26.49 - Investing.com Australia

Jun 09, 2025

Catalyst Pharmaceuticals Inc (CPRX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.67
price down icon 1.03%
$35.60
price up icon 0.17%
$102.58
price down icon 0.03%
$26.88
price up icon 1.05%
$110.44
price down icon 0.20%
biotechnology ONC
$290.46
price down icon 1.81%
자본화:     |  볼륨(24시간):